MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Pfizer

Closed

SectorHealthcare

24.31 -1.58

Overview

Share price change

24h

Current

Min

24.31

Max

24.86

Key metrics

By Trading Economics

Income

-4.1B

411M

Sales

63M

18B

P/E

Sector Avg

17.972

63.778

EPS

0.63

Dividend yield

6.79

Profit margin

2.314

Employees

81,000

EBITDA

-4.3B

2.5B

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+23.81% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

6.79%

2.39%

Next Earnings

29 Apr 2025

Next Dividend date

13 Jun 2025

Next Ex Dividend date

8 May 2025

Market Stats

By TradingEconomics

Market Cap

-7.5B

144B

Previous open

25.89

Previous close

24.31

News Sentiment

By Acuity

45%

55%

165 / 386 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

Pfizer Chart

Past performance is not a reliable indicator of future results.

Related News

19 Mar 2025, 07:34 UTC

Acquisitions, Mergers, Takeovers

Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion

18 Mar 2025, 17:26 UTC

Acquisitions, Mergers, Takeovers

Pfizer to Dispose of Remaining Shareholding in Haleon

4 Feb 2025, 18:52 UTC

Major Market Movers

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

4 Feb 2025, 14:58 UTC

Earnings
Major Market Movers

Pfizer Shares Rise on Better-Than-Expected 4Q

26 Mar 2025, 22:29 UTC

Top News

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- 2nd Update

26 Mar 2025, 19:19 UTC

Top News

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- Update

26 Mar 2025, 17:39 UTC

Top News

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- WSJ

18 Mar 2025, 16:58 UTC

Acquisitions, Mergers, Takeovers

Haleon Intends to Cancel Purchased Ordinary Shares

18 Mar 2025, 16:57 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Off-Market Transaction Will Close at Same Time as or Following Settlement of Offering

18 Mar 2025, 16:56 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Off-Market Purchase Worth Approx GBP170M in Ordinary Shares

18 Mar 2025, 16:56 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Haleon Agreed to Carry out Off-Market Purchase From Pfizer

18 Mar 2025, 16:52 UTC

Acquisitions, Mergers, Takeovers

Haleon Takes Note of Announcement

18 Mar 2025, 16:50 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Haleon Won't Receive Any Net Proceeds From Offering

18 Mar 2025, 16:50 UTC

Acquisitions, Mergers, Takeovers

Citigroup: This Is Subject to Customary Closing Conditions

18 Mar 2025, 16:50 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Pfizer Will Receive All of Net Proceeds From Offering

18 Mar 2025, 16:49 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Bookbuilding Period May Close at Any Time on Short Notice

18 Mar 2025, 16:49 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Bookbuilding Period Will Commence Immediately

18 Mar 2025, 16:49 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Price Per Sale Share to Be Determined Through Accelerated Bookbuilding Process

18 Mar 2025, 16:48 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Pfizer Intends to Sell Ordinary Shares to Institutional Investors

18 Mar 2025, 16:47 UTC

Acquisitions, Mergers, Takeovers

Citigroup:: Amount Is Pfizer's Entire Residual Shareholding in Haleon

18 Mar 2025, 16:47 UTC

Acquisitions, Mergers, Takeovers

Citigroup: This Represents Approx 7.3% Stake in Haleon

18 Mar 2025, 16:46 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Pfizer Intends to Sell Approx 662M Ordinary Shares in Haleon

17 Mar 2025, 09:00 UTC

Top News

Pfizer Has a New Playbook for Reviving Sales -- And It's Starting to Pay Off -- WSJ

28 Feb 2025, 12:00 UTC

Top News

Drug Stocks Are the New Safe Bet in a Shaky Market -- Heard on the Street -- WSJ

14 Feb 2025, 11:38 UTC

Top News
Earnings

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

14 Feb 2025, 11:30 UTC

Top News
Earnings

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

5 Feb 2025, 12:00 UTC

Top News

Merck Is Suffering From a Classic Pharma Problem -- Heard on the Street -- WSJ

4 Feb 2025, 19:34 UTC

Top News

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 3rd Update

4 Feb 2025, 19:10 UTC

Top News

Pfizer Falls on RFK's Progress Towards Confirmation Despite Good Earnings. Its CEO is Unbothered. -- Barrons.com

4 Feb 2025, 18:51 UTC

Top News

RFK Jr. Clears Committee Vote, Putting Him on Track to Become Health Secretary -- 2nd Update

Peer Comparison

Price change

Pfizer Forecast

Price Target

By TipRanks

23.81% upside

12 Months Forecast

Average 30.58 USD  23.81%

High 36 USD

Low 27 USD

Based on 15 Wall Street analysts offering 12 month price targets forPfizer - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

15 ratings

6

Buy

9

Hold

0

Sell

Technical Score

By Trading Central

24.52 / 25.23Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

165 / 386 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.